0222.KLSE Optimax Holdings Sdn Bhd
- Market cap
- MYR 269M
- P/E
- 25.0x
- P/B
- 3.57x
- ROE
- 17.3%
- Dividend yield
- 2.63%
- Fundamental score
- 2.7/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 0222.KLSE undervalued?
Graham number0222.KLSE trades 99.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Optimax Holdings Sdn Bhd fundamental analysis
14 of 22 checks passedROE 1/2
Moderate return on equity (17.3%), between 10% and 20%.
ROA 1/1
Return on assets (8.8%) is above the industry median (3.7%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (6.1%) is not above the 5-year average (21.2% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (6.1%) is below the industry median (6.1%).
Revenue Growth 1/2
Revenue grew 7.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (66.3%), up to 100%.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 8.5x against interest expense, well covered.
PE vs Market 0/1
PE (24.8x) is above the market median (11.4x).
PE vs Industry 1/1
PE (24.8x) is below the industry median (27.9x).
PBV 0/1
Price to book (3.5x) is above the industry median (2.2x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 87.5, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 1.17, above 1.
Dividend Yield 1/2
Dividend yield (2.6%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 51.4%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About Optimax Holdings Sdn Bhd
Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases and disorders, such as cataracts, glaucoma, refractive errors, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment …
Full company profileOptimax Holdings Sdn Bhd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Optimax Holdings Sdn Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 30.0M | 36.0M | 49.2M | 62.7M | 58.0M | 88.9M | 108M | 114M | 128M | 136M | 136M |
| Gross Profit | 23.8M | 27.8M | 38.7M | 26.2M | 45.9M | 69.4M | 84.4M | 43.8M | 102M | 37.8M | 36.1M |
| Operating Income | 5.34M | 10.5M | 9.03M | -3.88M | 11.1M | 19.7M | 24.6M | 21.2M | 22.5M | 23.0M | 22.7M |
| EBITDA | - | - | 14.4M | 19.6M | 17.0M | 26.2M | 32.6M | 31.1M | 37.2M | 39.5M | 39.6M |
| Net Income | 3.24M | 7.39M | 4.45M | 7.83M | 5.64M | 12.3M | 14.7M | 12.9M | 13.0M | 13.8M | 13.3M |
| EPS | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 32.4M | 40.3M | 56.2M | 63.9M | 84.2M | 92.6M | 101M | 120M | 149M | 148M | 150M |
| Total Liabilities | 20.2M | 23.9M | 35.4M | 39.7M | 34.0M | 34.9M | 39.4M | 51.8M | 75.3M | 76.0M | 66.9M |
| Shareholders' Equity | 12.2M | 16.3M | 20.8M | 22.7M | 47.9M | 55.0M | 58.1M | 63.0M | 67.8M | 73.6M | 76.8M |
| Cash & Short-term Investments | 2.80M | 3.20M | 5.53M | 6.75M | 25.0M | 23.2M | 23.1M | 19.2M | 17.9M | 22.8M | 23.6M |
| Total Debt | - | - | - | 25.3M | 26.4M | 24.1M | 26.1M | 33.1M | 58.9M | 49.8M | 51.0M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.29M | 8.13M | 12.9M | 17.7M | 13.0M | 19.7M | 27.1M | 25.3M | 23.9M | 30.6M | 21.5M |
| Capital Expenditure | 17.8M | 1.95M | 7.09M | 4.69M | 4.56M | 11.1M | 11.1M | 11.3M | 24.2M | 5.84M | 5.67M |
| Free Cash Flow | - | - | 5.81M | 13.0M | 8.40M | 8.61M | 15.9M | 13.5M | -313K | 24.8M | 15.8M |
| Ratios | |||||||||||
| ROE | 26.5% | 45.2% | 21.4% | 34.6% | 11.8% | 22.3% | 25.3% | 20.5% | 19.2% | 18.7% | 17.3% |
| ROA | 10.0% | 18.3% | 7.9% | 12.3% | 6.7% | 13.3% | 14.5% | 10.8% | 8.8% | 9.3% | 8.8% |
| Net Profit Margin | 10.8% | 20.5% | 9.0% | 12.5% | 9.7% | 13.8% | 13.6% | 11.3% | 10.2% | 10.1% | 9.8% |
| Debt to Equity | - | - | - | 1.12x | 0.55x | 0.44x | 0.45x | 0.53x | 0.87x | 0.68x | 0.66x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Optimax Holdings Sdn Bhd dividends
- Dividend yield
- 2.63%
- Forward dividend
- 0.01 MYR
- Payout ratio
- 51.4%
- Ex-dividend date
- Mar 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | MYR 7.06M | 0.01 | 51.4% |
| 2024 | MYR 7.59M | 0.01 | 58.3% |
| 2023 | MYR 9.74M | 0.02 | 75.6% |
| 2022 | MYR 11.6M | 0.02 | 79.0% |
| 2021 | MYR 5.13M | 0.01 | 41.7% |
| 2020 | MYR 5.13M | 0.01 | 90.9% |
| 2019 | MYR 6.00M | 0.02 | 76.6% |
| 2018 | - | - | - |
| 2017 | MYR 1.09M | 0.00 | 14.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on May 5, 2022.
Who owns Optimax Holdings Sdn Bhd
- Insiders 76.10%
- Institutions 6.30%
- Public & others 17.60%
- Shares outstanding 543M
- Free float 146M
Optimax Holdings Sdn Bhd company profile
- Company name
- Optimax Holdings Sdn Bhd
- Ticker
- 0222.KLSE
- ISIN
- MYQ0222OO008
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- December
- Address
- No.145, Jalan Radin Bagus, Kuala Lumpur, Malaysia, 57000
- Phone
- 60 3 9054 6186
- Website
- optimax2u.com
About Optimax Holdings Sdn Bhd
Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases and disorders, such as cataracts, glaucoma, refractive errors, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, medical consumable and eye examination services. In addition, the company markets food products; and retails pharmaceuticals, medical, orthopaedic goods, perfumery, cosmetics, and toilet articles. Further, it offers medical services related to ear, nose and throat; specialised medical services food or beverage, food and beverage preparation in market stalls/hawkers and retail sales of other food products. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. Holdings Berhad was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
Optimax Holdings Sdn Bhd management
5- Ms. Sing Yee TanCEO & Non-Independent Executive Director · born 1988
- Dr. Boon Hock TanExecutive Deputy Chairman · born 1956
- Mr. Woei Yaw PangChief Financial Officer · born 1989
- Ms. Chian Yen AngChief Operating Officer · born 1989
- Song En TanCompany Secretary